Drug Profile
YY OB
Alternative Names: YY-OBLatest Information Update: 28 Feb 2023
Price :
$50
*
At a glance
- Originator Yuyu
- Class Obesity therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Obesity
Most Recent Events
- 28 Feb 2023 No recent reports of development identified for preclinical development in Obesity in South Korea
- 02 Feb 2021 YY OB is still in preclinical trial for Obesity in South Korea (Yuyu pipeline, February 2021)
- 28 Feb 2020 No recent reports of development identified for preclinical development in Obesity in South Korea